Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Kirk Barber Research, CA /ID# 153840

Calgary, Alberta T2G 1B1, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Psoriasis

Closed trials

Completed
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
NCT03047395· Phase 3· AbbVie· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Kirk Barber Research, CA /ID# 153840: trial site – Frontlight Research